The effect of statins on mortality among patients with infection: Umbrella review of meta-analyses

R. A. Ghayda, C. H. Han, K. H. Lee, J. S. Kim, S. E. Kim, S. H. Hong, M. Kim, A. Kronbichler, K. Tizaoui, H. Li, A. Koyanagi, L. Jacob, M. S. Kim, D. K. Yon, S. W. Lee, K. Kostev, J. I. Shin, J. W. Yang, L. Smith

Research output: Contribution to journalReview articlepeer-review

Abstract

OBJECTIVE: Although previous research has reported beneficial effects of statins on infectious diseases, these have yet to be concluded. Therefore, we conducted an umbrella review to provide a comprehensive understanding of the strength of evidence and validity of claimed associations between statins (hydroxymethyl glutaryl-CoA reductase inhibitors) and infectious diseases. MATERIALS AND METHODS: We conducted an umbrella review and re-analyzed data from meta-analyses of randomized controlled trials and observational studies on associations between statin use and different infectious diseases such as bacteremia/sepsis and pneumonia. We also evaluated the level of evidence for each re-analyzed outcome based on the criteria using p-values of random and fixed-effects, 95% prediction intervals, small-study effects, between-study heterogeneity, and concordance between the effect estimate of the largest study and summary estimates of the meta-analysis. Moreover, publication bias was also examined. RESULTS: Through a systematic literature search, we obtained 14 eligible articles including 25 meta-analyses. All 4 meta-analyses on overall infection, 3 out of 14 meta-analyses on bacteremia/sepsis, and 5 out of 7 meta-analyses on pneumonia demonstrated that statin use was associated with reduced mortality due to infections (caused by infections). Nonetheless, most significant results only showed a weak level of evidence, and one study with convincing evidence prior to adjustment also showed weak evidence after adjustment. CONCLUSIONS: The present review identified a protective effect of statins on infection-related mortality, but all available studies had a weak level of evidence. Therefore, further studies with a strong level of evidence are needed, and it is also necessary to investigate the types of statins and to study clinical outcomes other than mortality to gain further insights.

Original languageEnglish
Pages (from-to)2685-2695
Number of pages11
JournalEuropean Review for Medical and Pharmacological Sciences
Volume25
Issue number6
DOIs
Publication statusPublished - 2021

Bibliographical note

Publisher Copyright:
© 2021 Verduci Editore s.r.l. All rights reserved.

All Science Journal Classification (ASJC) codes

  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'The effect of statins on mortality among patients with infection: Umbrella review of meta-analyses'. Together they form a unique fingerprint.

Cite this